Displaying drugs 276 - 300 of 473 in total
Aminomethylcyclohexane
Experimental
R-azabisabolene
Experimental
Tetrabutylammonium Ion
Experimental
1-Methylimidazole
Experimental
Bfpet F-18
Bfpet F-18 is under investigation in clinical trial NCT03265431 (Evaluation of PET/MR in Patients Selected for Ablation Therapy).
Investigational
Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine
Experimental
(1R,2S)-2-Phenylcyclopropanaminium
A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)
Experimental
Betaine aldehyde
Experimental
Emepronium
Experimental
Cobalt hexammine ion
Experimental
Tris-Hydroxymethyl-Methyl-Ammonium
Experimental
Guanidine-3-propanol
Experimental
Tetramethylammonium
Experimental
PROPYL-1-PHOSPHATE
Experimental
5-Amidino-Benzimidazole
Experimental
Benzamidine
Experimental
Hexamethonium
A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by...
Experimental
Thieno[2,3-B]Pyridine-2-Carboxamidine
Experimental
4-Hydroxybutan-1-Aminium
Experimental
Cyclohexylammonium Ion
Experimental
Bis(5-Amidino-Benzimidazolyl)Methane
Experimental
2-(Trimethylammonium)Ethyl Thiol
Experimental
Mercury Acetate Ion
Experimental
4-Fluorobenzylamine
Experimental
Displaying drugs 276 - 300 of 473 in total